Abstract
BackgroundIn the last years, glucocorticoids given in addition to disease-modifying anti-rheumatic drugs (DMARDs) have been used as disease modifying therapy. The potential cardiovascular (CV) risk of exposure to GCs is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have